Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-11 12:10 pm Purchase | 13G | BENITEC BIOPHARMA INC BNTC | ADAGE CAPITAL PARTNERS GP L.L.C. | 264,510 9.99% | 75,322 (+39.81%) | View |
| 2024-02-14 6:18 pm Sale | 13G | BENITEC BIOPHARMA INC BNTC | CITADEL ADVISORS LLC | 95,356 3.6% | -84,674 (-47.03%) | View |
| 2024-02-14 10:00 am Sale | 13G | BENITEC BIOPHARMA INC BNTC | JANUS HENDERSON GROUP PLC JHG | 180,399 7% | -25,771 (-12.50%) | View |
| 2024-02-13 5:16 pm Purchase | 13G | BENITEC BIOPHARMA INC BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 262,843 9.99% | 262,843 (New Position) | View |
| 2023-12-11 12:41 pm Purchase | 13G | BENITEC BIOPHARMA INC BNTC | FRANKLIN RESOURCES INC BEN | 588,237 22.9% | 2 (+0.00%) | View |
| 2023-09-11 11:27 am Purchase | 13G | BENITEC BIOPHARMA INC BNTC | FRANKLIN RESOURCES INC BEN | 588,235 28.5% | 588,235 (New Position) | View |
| 2023-08-25 4:30 pm Purchase | 13G | BENITEC BIOPHARMA INC BNTC | ADAGE CAPITAL PARTNERS GP L.L.C. | 189,188 7.5% | 189,188 (New Position) | View |
| 2023-08-21 4:07 pm Purchase | 13G | BENITEC BIOPHARMA INC BNTC | CITADEL ADVISORS LLC | 180,030 6.9% | 180,030 (New Position) | View |
| 2023-08-18 3:55 pm Purchase | 13G | BENITEC BIOPHARMA INC BNTC | JANUS HENDERSON GROUP PLC JHG | 206,170 9.9% | 206,170 (New Position) | View |
| 2023-08-18 10:50 am Sale | 13G | BENITEC BIOPHARMA INC BNTC | Oliveira Steven Michael | 98,203 3.89% | -1,985,968 (-95.29%) | View |
| 2023-04-18 4:16 pm Sale | 13G | BENITEC BIOPHARMA INC BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 3,020,214 9.99% | -3,308,484 (-52.28%) | View |
| 2023-02-14 11:24 am Sale | 13G | BENITEC BIOPHARMA INC BNTC | CVI Investments Inc. | 1,469,593 4.9% | -30,407 (-2.03%) | View |
| 2023-02-13 12:25 pm Purchase | 13G | BENITEC BIOPHARMA INC BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 6,328,698 9.99% | 5,559,698 (+722.98%) | View |
| 2023-02-07 5:38 pm Sale | 13G | BENITEC BIOPHARMA INC BNTC | SILVERARC CAPITAL MANAGEMENT LLC | 0 0% | -587,499 (Position Closed) | View |
| 2022-10-11 12:05 pm Purchase | 13G | BENITEC BIOPHARMA INC BNTC | FRANKLIN RESOURCES INC BEN | 10,000,000 38.7% | 10,000,000 (New Position) | View |
| 2022-10-07 12:46 pm Purchase | 13G | BENITEC BIOPHARMA INC BNTC | Oliveira Steven Michael | 2,084,171 8.08% | 1,416,048 (+211.94%) | View |
| 2022-09-23 10:11 am Purchase | 13G | BENITEC BIOPHARMA INC BNTC | CVI Investments Inc. | 1,500,000 5.8% | 1,500,000 (New Position) | View |
| 2022-02-10 09:09 am Unchanged | 13G | BENITEC BIOPHARMA INC BNTC | SILVERARC CAPITAL MANAGEMENT LLC | 587,499 7.2% | 0 (Unchanged) | View |
| 2022-02-10 09:07 am Unchanged | 13G | BENITEC BIOPHARMA INC BNTC | SILVERARC CAPITAL MANAGEMENT LLC | 587,499 7.2% | 0 (Unchanged) | View |
| 2022-02-09 4:39 pm Purchase | 13G | BENITEC BIOPHARMA INC BNTC | SILVERARC CAPITAL MANAGEMENT LLC | 587,499 7.2% | 587,499 (New Position) | View |